Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss

Articles From: Chimerix Announces Completion of Initial Public Offering and Exercise of Underwriters' Over-allotment Option to China Biologic Products to Report Fourth Quarter and Fiscal Year 2012 Financial Results

This site contains about 63,386 documents.
View by:
Title  |  Date  |  Author  |  Collection  |  Interest  |  Popularity
Page:   1   100   280   290   300   310   320   330   340   350   360   367   368   369   370   371   372   373   374   375   376   377   378   379   380   381   382   383   384   385   386   387   388   389   390   391   392   393   394   395   396   400   410   420   430   440   450   460   470   480   500   600   700   800   900   1,000   1,100   1,200   1,300   2,000   2,113 

2013/4/16
Chimerix Announces Completion of Initial Public Offering and Exercise of Underwriters' Over-allotment Option
RESEARCH TRIANGLE PARK, N.C., April 16, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today the completion of its initial public offering of 8,418,000 shares of its common stock at an initial public offering price of $14.00 per share.
View more Chimerix Announces Completion of Initial Public Offering and Exercise of Underwriters' Over-allotment Option analysis
Sign-up for Chimerix Announces Completion of Initial Public Offering and Exercise of Underwriters' Over-allotment Option investment picks
2013/4/24
Chimerix Announces Final Study Design for Phase 3 SUPPRESS Trial of CMX001 for Prevention of CMV Infection
CMX001 demonstrated potential clinical utility in prevention of CMV infection in Phase 2 SUPPRESS trial anticipated to begin dosing mid-2013 with topline data expected in 2015 DURHAM, N.C., April 24, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today the final study design for the Phase 3 SUPPRESS trial of CMX001 in the prevention of cytomegalovirus (CMV) infection following an allogeneic hematopoietic stem cell transplant (HSCT). CMX001 is an investigational oral nucleotide analog lipid-conjugate that has shown broad-spectrum antiviral activity against double-stranded DNA (dsDNA) viruses including all of the herpesviruses, adenoviruses and polyomaviruses.
View more Chimerix Announces Final Study Design for Phase 3 SUPPRESS Trial of CMX001 for Prevention of CMV Infection analysis
Sign-up for Chimerix Announces Final Study Design for Phase 3 SUPPRESS Trial of CMX001 for Prevention of CMV Infection investment picks
2013/5/13
Chimerix Announces First Quarter 2013 Financial Results
DURHAM, N.C., May 13, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today reported financial results for the quarter ended March 31, 2013.
View more Chimerix Announces First Quarter 2013 Financial Results analysis
Sign-up for Chimerix Announces First Quarter 2013 Financial Results investment picks
2013/4/11
Chimerix Announces Pricing of Initial Public Offering
RESEARCH TRIANGLE PARK, N.C., April 11, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today the pricing of its initial public offering of 7,320,000 shares of its common stock at a price to the public of $14.00 per share.
View more Chimerix Announces Pricing of Initial Public Offering analysis
Sign-up for Chimerix Announces Pricing of Initial Public Offering investment picks
2013/4/29
Chimerix Presents at Annual EBMT Meeting: Antiviral Activity of CMX001 in Patients With Life-Threatening Viral Infections
CMX001 demonstrated positive clinical activity against life-threatening adenovirus infection in patients enrolled in the CMX001 Compassionate Use Program A significant proportion of patients in the CMX001 Compassionate Use Program had evidence of active infection with more than one virus DURHAM, N.C., April 29, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today the presentation of the first clinical outcomes data on the use of CMX001 in patients with life-threatening infection with adenovirus (AdV), a disease with no approved therapy.
View more Chimerix Presents at Annual EBMT Meeting: Antiviral Activity of CMX001 in Patients With Life-Threatening Viral Infections analysis
Sign-up for Chimerix Presents at Annual EBMT Meeting: Antiviral Activity of CMX001 in Patients With Life-Threatening Viral Infections investment picks
2013/5/6
Chimerix to Announce First Quarter Financial Results on May 13, 2013
DURHAM, N.C., May 6, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today that it will report financial results for the first quarter ending March 31, 2013, on Monday, May 13, 2013, before the market opens.
View more Chimerix to Announce First Quarter Financial Results on May 13, 2013 analysis
Sign-up for Chimerix to Announce First Quarter Financial Results on May 13, 2013 investment picks
2013/4/26
Chimerix to Present at the 12th Annual Needham Healthcare Conference
DURHAM, N.C., April 26, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today that Kenneth I.
View more Chimerix to Present at the 12th Annual Needham Healthcare Conference analysis
Sign-up for Chimerix to Present at the 12th Annual Needham Healthcare Conference investment picks
2013/5/16
Chimerix's CMX001 Resistance Data Presented at the 26th International Conference on Antiviral Research
DURHAM, N.C., May 16, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, recently presented data demonstrating CMX001's high barrier to viral resistance in the prevention and treatment of cytomegalovirus (CMV) infection.
View more Chimerix's CMX001 Resistance Data Presented at the 26th International Conference on Antiviral Research analysis
Sign-up for Chimerix's CMX001 Resistance Data Presented at the 26th International Conference on Antiviral Research investment picks
2013/2/15
Chimicles & Tikellis LLP, Labaton Sucharow LLP, Chitwood Harley Harnes LLP Announce Summary Notice Of Pendency And Proposed Settlements Of Class Actions And Settlement Hearing
In Re Wells Real Estate Investment Trust, Inc. Securities Litigation ("Wells Action"), Civil Action No.
View more Chimicles & Tikellis LLP, Labaton Sucharow LLP, Chitwood Harley Harnes LLP Announce Summary Notice Of Pendency And Proposed Settlements Of Class Actions And Settlement Hearing analysis
Sign-up for Chimicles & Tikellis LLP, Labaton Sucharow LLP, Chitwood Harley Harnes LLP Announce Summary Notice Of Pendency And Proposed Settlements Of Class Actions And Settlement Hearing investment picks
2013/3/1
China ACE Awards 2013 -- Broadcom, Texas Instruments, Freescale Semiconductor, NXP Semiconductors, Analog Devices and Agilent Technologies among winners
Awards ceremony held during International IC-China Conference & Exhibition in Shenzhen; Broadcom named Company of the Year for the second time; Wayne Dai of VeriSilicon honored as Executive of the Year   SHENZHEN, China , March 1, 2013 /PRNewswire/ -- Analog Devices, Texas Instruments, NXP Semiconductors, Freescale Seminiconductor, Broadcom and Agilent Technologies are among the winners of the China Annual Creativity in Electronics ( ACE ) Awards 2013 , presented during a reception held today in conjunction with the 18th International IC-China Conference & Exhibition ( IIC-China ), which is running until March 2, 2013 at the Shenzhen Convention & Exhibition Center.
View more China ACE Awards 2013 -- Broadcom, Texas Instruments, Freescale Semiconductor, NXP Semiconductors, Analog Devices and Agilent Technologies among winners analysis
Sign-up for China ACE Awards 2013 -- Broadcom, Texas Instruments, Freescale Semiconductor, NXP Semiconductors, Analog Devices and Agilent Technologies among winners investment picks
2013/5/15
China ACM Reports Third Quarter Fiscal Year 2013 Results, Provides Quarterly Guidance for the Fourth Quarter of Fiscal Year 2013, and Updates the Yearly Guidance for Fiscal Year 2013
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G005147-001&sourceType=1 BEIJING --(Marketwired - May 15, 2013) - China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) ("China ACM" or the "Company"), a provider of ready-mix concrete and related technical services in China, has announced its financial results for the third quarter of fiscal year 2013 ended March 31, 2013.
View more China ACM Reports Third Quarter Fiscal Year 2013 Results, Provides Quarterly Guidance for the Fourth Quarter of Fiscal Year 2013, and Updates the Yearly Guidance for Fiscal Year 2013 analysis
Sign-up for China ACM Reports Third Quarter Fiscal Year 2013 Results, Provides Quarterly Guidance for the Fourth Quarter of Fiscal Year 2013, and Updates the Yearly Guidance for Fiscal Year 2013 investment picks
2013/2/8
China ACM to Report the Second Quarter Fiscal Year 2013 Financial Results on February 15, 2013
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G003608-001&sourceType=1 BEIJING --(Marketwire - February 08, 2013) - China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) ("China ACM"), a provider of ready-mix concrete and related technical services in China, will host a conference call with a live webcast and a full Q&A session on February 15, 2013, at 8:00 a.m., Eastern Time, to discuss financial results for the second quarter of Fiscal Year 2013.
View more China ACM to Report the Second Quarter Fiscal Year 2013 Financial Results on February 15, 2013 analysis
Sign-up for China ACM to Report the Second Quarter Fiscal Year 2013 Financial Results on February 15, 2013 investment picks
2013/5/12
China ACM to Report Third Quarter Fiscal Year 2013 Financial Results on May 16, 2013
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G005063-001&sourceType=1 BEIJING --(Marketwired - May 12, 2013) - China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) ("China ACM"), a provider of ready-mix concrete and related technical services in China, will host a conference call with a live webcast and a full Q&A session on May 16, 2013, at 8:00 a.m., Eastern Time, to discuss financial results for the third quarter of Fiscal Year 2013.
View more China ACM to Report Third Quarter Fiscal Year 2013 Financial Results on May 16, 2013 analysis
Sign-up for China ACM to Report Third Quarter Fiscal Year 2013 Financial Results on May 16, 2013 investment picks
2013/5/1
China April HSBC Final Manufacturing PMI 50.4 Vs 51.6 in March
BEIJING --The HSBC China Manufacturing Purchasing Managers' Index, a gauge of nationwide manufacturing activity, fell to a final reading of 50.4 in April from 51.6 in March, HSBC Holdings PLC said Thursday.
View more China April HSBC Final Manufacturing PMI 50.4 Vs 51.6 in March analysis
Sign-up for China April HSBC Final Manufacturing PMI 50.4 Vs 51.6 in March investment picks
2013/5/1
China April HSBC Manufacturing PMI Falls
A leading indicator of China's manufacturing strength dropped in April, adding to signs of weakness in the world's second-largest economy.
View more China April HSBC Manufacturing PMI Falls analysis
Sign-up for China April HSBC Manufacturing PMI Falls investment picks
2013/3/25
China Armco Metals to Host Fourth Quarter & Year End 2012 Earnings Conference Call on Monday, April 1, 2013 at 5:00 p.m. EDT
SAN MATEO, Calif.
View more China Armco Metals to Host Fourth Quarter & Year End 2012 Earnings Conference Call on Monday, April 1, 2013 at 5:00 p.m. EDT analysis
Sign-up for China Armco Metals to Host Fourth Quarter & Year End 2012 Earnings Conference Call on Monday, April 1, 2013 at 5:00 p.m. EDT investment picks
2013/2/6
China Armco Updates Recycling Business on New Qualification and Orders - China Armco Metals becomes Demonstration Base for Steel Scrap Processing and Distribution in China and may receive tax benefits
SAN MATEO, Calif.
View more China Armco Updates Recycling Business on New Qualification and Orders - China Armco Metals becomes Demonstration Base for Steel Scrap Processing and Distribution in China and may receive tax benefits analysis
Sign-up for China Armco Updates Recycling Business on New Qualification and Orders - China Armco Metals becomes Demonstration Base for Steel Scrap Processing and Distribution in China and may receive tax benefits investment picks
2013/3/22
China Auto Logistics 2012 Year End Investor Conference Call Scheduled for Tuesday, April 2nd at 8:00am ET
http://media.marketwire.com/attachments/201205/46039_CALIimg.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=999654&ProfileId=051205&sourceType=1 TIANJIN, CHINA --
View more China Auto Logistics 2012 Year End Investor Conference Call Scheduled for Tuesday, April 2nd at 8:00am ET analysis
Sign-up for China Auto Logistics 2012 Year End Investor Conference Call Scheduled for Tuesday, April 2nd at 8:00am ET investment picks
2013/5/9
China Auto Logistics 2013 First Quarter Investor Conference Call Scheduled for Friday, May 17th at 8:00am ET
http://media.marketwire.com/attachments/201205/46039_CALIimg.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1015613&ProfileId=051205&sourceType=1 TIANJIN, CHINA --
View more China Auto Logistics 2013 First Quarter Investor Conference Call Scheduled for Friday, May 17th at 8:00am ET analysis
Sign-up for China Auto Logistics 2013 First Quarter Investor Conference Call Scheduled for Friday, May 17th at 8:00am ET investment picks
2013/5/15
China Auto Logistics Reports 2013 First Quarter Results
http://media.marketwire.com/attachments/201205/46039_CALIimg.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1017699&ProfileId=051205&sourceType=1 TIANJIN, CHINA --
View more China Auto Logistics Reports 2013 First Quarter Results analysis
Sign-up for China Auto Logistics Reports 2013 First Quarter Results investment picks
2013/4/1
China Auto Logistics' 2012 Revenue Grew 31% Year Over Year Led by Another Record Year in Luxury Auto Sales
http://media.marketwire.com/attachments/201205/46039_CALIimg.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1002300&ProfileId=051205&sourceType=1 TIANJIN, CHINA --
View more China Auto Logistics' 2012 Revenue Grew 31% Year Over Year Led by Another Record Year in Luxury Auto Sales analysis
Sign-up for China Auto Logistics' 2012 Revenue Grew 31% Year Over Year Led by Another Record Year in Luxury Auto Sales investment picks
2013/5/9
China Auto Sales Up 13% in April; Growth Seen Slowing
China's auto sales increased 13% in April from a year earlier, accelerating from the previous month in spite of indicators showing the country's economic recovery falling short of expectations.
View more China Auto Sales Up 13% in April; Growth Seen Slowing analysis
Sign-up for China Auto Sales Up 13% in April; Growth Seen Slowing investment picks
2013/5/14
China Automotive Systems Reports First-Quarter Record Net Sales and Higher Net Income
WUHAN, China , May 14, 2013 /PRNewswire-FirstCall/ -- China Automotive Systems, Inc. ("CAAS" or the "Company") (NASDAQ: CAAS) , a leading power steering components and systems supplier in China , today announced its unaudited financial results for the first quarter ended March 31, 2013 .
View more China Automotive Systems Reports First-Quarter Record Net Sales and Higher Net Income analysis
Sign-up for China Automotive Systems Reports First-Quarter Record Net Sales and Higher Net Income investment picks
2013/3/27
China Automotive Systems Reports Higher Net Sales for the Fourth Quarter and Fiscal Year 2012
WUHAN, China , March 27, 2013 /PRNewswire-FirstCall/ --  China Automotive Systems, Inc. ("CAAS" or the "Company") (NASDAQ: CAAS) , a leading power steering components and systems supplier in China , today announced its financial results for the fourth quarter and the fiscal year ended December 31, 2012 .
View more China Automotive Systems Reports Higher Net Sales for the Fourth Quarter and Fiscal Year 2012 analysis
Sign-up for China Automotive Systems Reports Higher Net Sales for the Fourth Quarter and Fiscal Year 2012 investment picks
2013/3/19
China Automotive Systems To Announce 2012 Fourth Quarter Financial Results on March 27, 2013
Teleconference to be held at 8:00 A.M. EDT/8:00 P.M. Beijing Time WUHAN, China , March 19, 2013 /PRNewswire-FirstCall/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) , a leading power steering components and systems supplier in China , today announced that it will issue financial results for the 2012 fourth quarter and year ended December 31, 2012 on Wednesday, March 27, 2013 before the market opens.
View more China Automotive Systems To Announce 2012 Fourth Quarter Financial Results on March 27, 2013 analysis
Sign-up for China Automotive Systems To Announce 2012 Fourth Quarter Financial Results on March 27, 2013 investment picks
2013/5/7
China Automotive Systems To Announce 2013 First Quarter Financial Results on May 14, 2013
-Teleconference to be held at 8:00 A.M. EDT/8:00 P.M. Beijing Time- WUHAN, China , May 7, 2013 /PRNewswire-FirstCall/ --  China Automotive Systems, Inc. (NASDAQ: CAAS) , a leading power steering components and systems supplier in China, today announced that it will issue financial results for the 2013 first quarter ended March 31, 2013 on Tuesday, May 14, 2013 before the market opens.
View more China Automotive Systems To Announce 2013 First Quarter Financial Results on May 14, 2013 analysis
Sign-up for China Automotive Systems To Announce 2013 First Quarter Financial Results on May 14, 2013 investment picks
2013/5/2
China Automotive Systems Wins Multi-Year Contract With SAIC-GM-Wuling
WUHAN, China , May 2, 2013 /PRNewswire-FirstCall/ --
View more China Automotive Systems Wins Multi-Year Contract With SAIC-GM-Wuling analysis
Sign-up for China Automotive Systems Wins Multi-Year Contract With SAIC-GM-Wuling investment picks
2013/1/30
China Automotive Systems Won the 2012 Annual Chrysler China Regional Excellent Supplier Award
WUHAN, China , Jan.
View more China Automotive Systems Won the 2012 Annual Chrysler China Regional Excellent Supplier Award analysis
Sign-up for China Automotive Systems Won the 2012 Annual Chrysler China Regional Excellent Supplier Award investment picks
2013/5/2
China Biologic Products to Report First Quarter 2013 Financial Results
BEIJING , May 2, 2013 /PRNewswire-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company plans to release first quarter 2013 financial results on Wednesday, May 8, 2013 after the market closes.
View more China Biologic Products to Report First Quarter 2013 Financial Results analysis
Sign-up for China Biologic Products to Report First Quarter 2013 Financial Results investment picks
2013/3/8
China Biologic Products to Report Fourth Quarter and Fiscal Year 2012 Financial Results
BEIJING , March 8, 2013   /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company plans to release fourth quarter and fiscal year 2012 financial results on Wednesday, March 13, 2013 after the market closes.
View more China Biologic Products to Report Fourth Quarter and Fiscal Year 2012 Financial Results analysis
Sign-up for China Biologic Products to Report Fourth Quarter and Fiscal Year 2012 Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
Articles From: Chimerix Announces Completion of Initial Public Offering and Exercise of Underwriters' Over-allotment Option to China Biologic Products to Report Fourth Quarter and Fiscal Year 2012 Financial Results
Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Mutual Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title
ETFs by:
Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name
Investment Categories by:
Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry
Premimum Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Premimum Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title
Premimum ETFs by:
Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name
Popular Articles by:
Title |  Date |  Author |  Collection |  Popularity |  Interest
SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Popular SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.